We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

75 hedge funds and large institutions have $36.5M invested in Adverum Biotechnologies in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 21

0.4% less ownership

Funds ownership: 3.62% → 3.22% (-0.4%)

10% less funds holding

Funds holding: 83 → 75 (-8)

17% less capital invested

Capital invested by funds: $43.8M → $36.5M (-$7.27M)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $28K

Holders
75
Holders Change
-8
Holders Change %
-9.64%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
23
Reduced
21
Closed
15
Calls
–
Puts
$28K
Net Calls
-$28K
Net Calls Change
+$35K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.99M
2
CC
Casdin Capital
New York
+$1.19M
3
AIC
AWM Investment Company
New York
+$569K
4
Renaissance Technologies
Renaissance Technologies
New York
+$490K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$411K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.66M
2
BCM
Bridgeway Capital Management
Texas
-$511K
3
Norges Bank
Norges Bank
Norway
-$485K
4
NI
Numeric Investors
Massachusetts
-$419K
5
GPCM
Granite Point Capital Management
Massachusetts
-$377K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$7.48M -$2.66M -93,585 -25%
BlackRock
2
BlackRock
New York
$3.8M +$3.99M +140,118 +26,487%
Renaissance Technologies
3
Renaissance Technologies
New York
$3.08M +$490K +17,228 +18%
NI
4
Numeric Investors
Massachusetts
$2.94M -$419K -14,738 -12%
EC
5
EcoR1 Capital
California
$2.36M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.7M +$411K +14,452 +30%
Primecap Management
7
Primecap Management
California
$1.19M +$42.1K +1,480 +3%
CC
8
Casdin Capital
New York
$1.13M +$1.19M +42,000 New
6CM
9
683 Capital Management
New York
$945K +$284K +10,000 +40%
State Street
10
State Street
Massachusetts
$899K +$31K +1,090 +3%
PAM
11
Panagora Asset Management
Massachusetts
$801K +$321K +11,291 +61%
Millennium Management
12
Millennium Management
New York
$786K -$137K -4,834 -14%
SM
13
Sabby Management
Florida
$763K -$1.93K -68 -0.2%
VMI
14
VHCP Management II
New York
$756K – – –
Connor, Clark & Lunn Investment Management (CC&L)
15
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$619K -$2.84K -100 -0.4%
Northern Trust
16
Northern Trust
Illinois
$595K -$6.97K -245 -1%
AIC
17
AWM Investment Company
New York
$540K +$569K +20,000 New
BCM
18
Bridgeway Capital Management
Texas
$497K -$511K -17,950 -49%
JAM
19
JW Asset Management
Florida
$482K – – –
RPAM
20
Rhenman & Partners Asset Management
Sweden
$416K – – –
Geode Capital Management
21
Geode Capital Management
Massachusetts
$365K +$11.6K +408 +3%
Deutsche Bank
22
Deutsche Bank
Germany
$341K +$59.2K +2,082 +20%
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$318K +$187K +6,590 +127%
Schroder Investment Management Group
24
Schroder Investment Management Group
United Kingdom
$300K – – –
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$295K +$218K +7,669 +236%
1
2 3 4

ADVM Hedge Fund Activity: Q1 2017 in Review

75 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q1 2017, worth a combined $36.5M — down 17% from $43.8M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ADVM and 12 opened new positions — a net loss of 3 holders — while 21 trimmed existing stakes and 23 added.

The largest buyer was BlackRock, adding an estimated $3.99M. The largest seller was Fidelity Investments, cutting an estimated $2.66M.

  • 75 institutional investors held Adverum Biotechnologies (ADVM) as of Q1 2017, down from 83 in Q4 2016.
  • Funds reported $36.5M of Adverum Biotechnologies stock for Q1 2017, down 17% quarter-over-quarter.
  • 12 funds opened new Adverum Biotechnologies positions in Q1 2017 and 15 closed out, a net change of -3 holders.
  • The largest Adverum Biotechnologies buyer in Q1 2017 was BlackRock, an estimated $3.99M added.
  • The largest Adverum Biotechnologies seller in Q1 2017 was Fidelity Investments, an estimated $2.66M sold.

Based on aggregated 13F filings for Q1 2017.